Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.

Glišić S, Cavanaugh DP, Chittur KK, Sencanski M, Perovic V, Bojić T.

BMC Bioinformatics. 2016 Mar 22;17:139. doi: 10.1186/s12859-016-0988-7.

2.

In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope.

Bojić T, Perović VR, Glišić S.

Front Neurosci. 2016 Jan 21;9:520. doi: 10.3389/fnins.2015.00520. eCollection 2015.

3.

Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic.

Veljkovic V, Paessler S, Glisic S, Prljic J, Perovic VR, Veljkovic N, Scotch M.

Front Microbiol. 2015 Dec 22;6:1456. doi: 10.3389/fmicb.2015.01456. eCollection 2015.

4.

The importance of MDR1 gene polymorphisms for tacrolimus dosage.

Kravljaca M, Perovic V, Pravica V, Brkovic V, Milinkovic M, Lausevic M, Naumovic R.

Eur J Pharm Sci. 2016 Feb 15;83:109-13. doi: 10.1016/j.ejps.2015.12.020. Epub 2015 Dec 17.

PMID:
26705892
5.

Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cells.

Srdic-Rajic T, Nikolic K, Cavic M, Djokic I, Gemovic B, Perovic V, Veljkovic N.

Eur J Pharm Sci. 2016 Jan 1;81:172-80. doi: 10.1016/j.ejps.2015.10.017. Epub 2015 Oct 24.

PMID:
26598394
6.

Case Report: Disparate flow in HeartMate II patient with extensive left ventricle repair.

Tran PL, Kazui T, Perovic V, Mikail P, Lick S, Smith R, Betterton EW, Venkat R, Iwanski J, Wong RK, Slepian MJ, Khalpey Z.

Perfusion. 2016 May;31(4):349-52. doi: 10.1177/0267659115614639. Epub 2015 Nov 2.

PMID:
26531760
7.

Natural Products as Promising Therapeutics for Treatment of Influenza Disease.

Sencanski M, Radosevic D, Perovic V, Gemovic B, Stanojevic M, Veljkovic N, Glisic S.

Curr Pharm Des. 2015;21(38):5573-88.

PMID:
26429712
8.

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease.

Veljkovic V, Goeijenbier M, Glisic S, Veljkovic N, Perovic VR, Sencanski M, Branch DR, Paessler S.

F1000Res. 2015 May 1;4:104. doi: 10.12688/f1000research.6436.1. eCollection 2015.

9.

Improving attrition rates in Ebola virus drug discovery.

Glisic S, Paessler S, Veljkovic N, Perovic VR, Prljic J, Veljkovic V.

Expert Opin Drug Discov. 2015;10(9):1025-32. doi: 10.1517/17460441.2015.1062872. Epub 2015 Jun 30. Review.

PMID:
26125997
10.

In silico analysis suggests interaction between Ebola virus and the extracellular matrix.

Veljkovic V, Glisic S, Muller CP, Scotch M, Branch DR, Perovic VR, Sencanski M, Veljkovic N, Colombatti A.

Front Microbiol. 2015 Feb 19;6:135. doi: 10.3389/fmicb.2015.00135. eCollection 2015.

11.

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection.

Veljkovic V, Loiseau PM, Figadere B, Glisic S, Veljkovic N, Perovic VR, Cavanaugh DP, Branch DR.

F1000Res. 2015 Feb 2;4:34. doi: 10.12688/f1000research.6110.1. eCollection 2015.

12.

Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism.

Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A.

Vaccine. 2014 Nov 12;32(48):6569-75. doi: 10.1016/j.vaccine.2014.07.007. Epub 2014 Jul 19.

PMID:
25045818
13.

Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells.

Ristic B, Bosnjak M, Arsikin K, Mircic A, Suzin-Zivkovic V, Bogdanovic A, Perovic V, Martinovic T, Kravic-Stevovic T, Bumbasirevic V, Trajkovic V, Harhaji-Trajkovic L.

Exp Cell Res. 2014 Aug 1;326(1):90-102. doi: 10.1016/j.yexcr.2014.05.021. Epub 2014 Jun 5.

PMID:
24907655
14.

Inhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic death.

Bosnjak M, Ristic B, Arsikin K, Mircic A, Suzin-Zivkovic V, Perovic V, Bogdanovic A, Paunovic V, Markovic I, Bumbasirevic V, Trajkovic V, Harhaji-Trajkovic L.

PLoS One. 2014 Apr 8;9(4):e94374. doi: 10.1371/journal.pone.0094374. eCollection 2014.

15.

Feature-based classification of amino acid substitutions outside conserved functional protein domains.

Gemovic B, Perovic V, Glisic S, Veljkovic N.

ScientificWorldJournal. 2013 Nov 17;2013:948617. doi: 10.1155/2013/948617. eCollection 2013.

16.

Spatial modeling of ecological areas by fitting the limiting factors for As in the vicinity of mine, Serbia.

Cakmak D, Perovic V, Saljnikov E, Jaramaz D, Sikiric B.

Environ Sci Pollut Res Int. 2014 Mar;21(5):3764-73. doi: 10.1007/s11356-013-2320-7. Epub 2013 Nov 27.

PMID:
24281676
17.

Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission.

Perovic VR, Muller CP, Niman HL, Veljkovic N, Dietrich U, Tosic DD, Glisic S, Veljkovic V.

PLoS One. 2013 Apr 26;8(4):e61572. doi: 10.1371/journal.pone.0061572. Print 2013.

18.

New in silico and conventional in vitro approaches to advance HIV drug discovery and design.

Maga G, Veljkovic N, Crespan E, Spadari S, Prljic J, Perovic V, Glisic S, Veljkovic V.

Expert Opin Drug Discov. 2013 Jan;8(1):83-92. doi: 10.1517/17460441.2013.741118. Epub 2012 Nov 20. Review.

PMID:
23167743
19.

The role of long-range intermolecular interactions in discovery of new drugs.

Veljkovic N, Glisic S, Perovic V, Veljkovic V.

Expert Opin Drug Discov. 2011 Dec;6(12):1263-70. doi: 10.1517/17460441.2012.638280. Epub 2011 Nov 15.

PMID:
22647065
20.

Simple and general criterion for "in silico" screening of candidate HIV drugs.

Veljkovic N, Glisic S, Prljic J, Perovic V, Veljkovic V.

Curr Pharm Biotechnol. 2013;14(5):561-9. Review.

PMID:
22429138
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk